Sort   by:  
 Page size 
UnknownMultimodal Inhibition of <i>Pectobacterium brasiliense</i> Virulence by the Citrus Flavanone Naringenin.
Not available
S-EPMC12371876 | biostudies-literature
UnknownPredicting success in regulatory approval from Phase I results.
Not available
S-EPMC4489154 | biostudies-literature
UnknownTh2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.
Not available
S-EPMC3574290 | biostudies-literature
UnknownSafety and Pharmacodynamics of the PDE4 Inhibitor Roflumilast in Advanced B-cell Malignancies.
Not available
S-EPMC5316514 | biostudies-literature
UnknownSafety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study.
Not available
S-EPMC6153548 | biostudies-literature
UnknownObesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes.
Not available
S-EPMC3741281 | biostudies-literature
UnknownMetformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II Diabetes.
Not available
S-EPMC5042809 | biostudies-literature
UnknownWTAP is a novel oncogenic protein in acute myeloid leukemia.
Not available
S-EPMC4369791 | biostudies-literature
TranscriptomicsWTAP is a novel oncogenic protein in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) continues to have the lowest survival rates of all leukemias. Therefore, new therapeutic strategies are urgently needed to improve clinical outcomes for AML patients. Here, we report a novel role for Wilms’ tumor 1-associated protein (WTAP) in pathogenesis of AML. We hav...
ORGANISM(S): Homo sapiens 
2014-01-22 | E-GEOD-46718 | biostudies-arrayexpress
UnknownTreating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein.
Not available
S-EPMC11357852 | biostudies-literature
Sort   by:  
 Page size